APA (7th ed.) Citation

A, G., GW, C., DJ, H., GJ, J., B, B., S, C., & DH, C. (2015). Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2). Clinical and experimental rheumatology, 33(3), 297.

Chicago Style (17th ed.) Citation

A, Gibofsky, Cannon GW, Harrison DJ, Joseph GJ, Bitman B, Chaudhari S, and Collier DH. "Discontinuation of Disease-modifying Anti-rheumatic Drugs and Clinical Outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)." Clinical and Experimental Rheumatology 33, no. 3 (2015): 297.

MLA (9th ed.) Citation

A, Gibofsky, et al. "Discontinuation of Disease-modifying Anti-rheumatic Drugs and Clinical Outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)." Clinical and Experimental Rheumatology, vol. 33, no. 3, 2015, p. 297.